Education
About Us
Working with TipRanks
Follow Us
Carrie Smith Cox Insider Profile
11 Followers
Carrie Smith Cox, Director at Celgene, holds 37.10K shares in Texas Instruments (Ticker: TXN), holds 15.63K shares in Cartesian Therapeutics (Ticker: RNAC), holds 41.63K shares in Cardinal Health (Ticker: CAH).
Profitable Transactions
2 out of 11 Profitable Transactions
Average Return
-36.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Carrie Smith Cox holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 15, 2022 - Jun 15, 2023
Return:+9.50%
The most profitable trade made by Carrie Smith Cox
Carrie Smith Cox's Trading History
Celgene
Nov 22, 2019
―
Uninformative Sell
―
$0.00
Array Biopharma
Jul 30, 2019
―
Uninformative Sell
384.00K
$0.00
Electrocore
Jun 06, 2019
Director
Informative Buy
18.20K
$296.10K
Cartesian Therapeutics
Jan 06, 2025
Director
Uninformative Buy
―
$287.57K
Organon
―
Director
―
―
Solventum Corporation
―
Director
―
―
Cardinal Health
Nov 10, 2022
Director
Uninformative Buy
―
$5.27M
Texas Instruments
Jan 29, 2025
Director
Uninformative Buy
―
$7.07M
Merck & Company
Nov 04, 2009
EVP
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Carrie Smith Cox's performance on stock
You May Also Like
Carrie Smith Cox insider profile FAQ
What is the percentage of profitable transactions made by Carrie Smith Cox?
The percentage of profitable transactions made by Carrie Smith Cox is 18%.
What is the average return per transaction made by Carrie Smith Cox?
The average return per transaction made by Carrie Smith Cox is -36.30%.
What stocks does Carrie Smith Cox hold?
Carrie Smith Cox holds: CELG, ~ARRY, ECOR, RNAC, OGN, SOLV, CAH, TXN, MRK stocks.
What was Carrie Smith Cox’s latest transaction?
Carrie Smith Cox latest transaction was an Uninformative Buy of ―.
What was Carrie Smith Cox's most profitable transaction?
Carrie Smith Cox’s most profitable transaction was an Informative Buy of RNAC stock on June 15, 2022. The return on the trade was 9.50%.
What is Carrie Smith Cox's role in Celgene?
Carrie Smith Cox's role in Celgene is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.